NGNE Neurogene PE ratio, current and historical analysis

The current PE ratio of NGNE cannot be calculated, as the latest EPS of -$4.28 is negative.

NGNE PE ratio history

How has NGNE's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Neurogene PE ratio by year

Year PE ratio PE change Price EPS
2024 N/A N/A $22.86 -$4.28
2023 N/A N/A $19.38 -$117.28
2022 N/A N/A $10.18 -$139.88
2021 N/A N/A $96.4 -$22
2020 N/A N/A $282 -$12.8
2019 N/A N/A $246.4 -$51.4
2018 N/A N/A $43.2 -$26.8
2017 N/A N/A $235.2 -$42.8
2016 N/A N/A $330.2 -$39.2
2015 N/A N/A $249.6 -$34.6
2014 N/A N/A $150 -$55
2013 N/A N/A N/A -$990.4
2012 N/A N/A N/A -$804.6

Neurogene PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 N/A N/A $22.86 -$4.28
Sep 2024 N/A N/A $41.96 -$32.9
Jun 2024 N/A N/A $36.39 -$64.38
Mar 2024 N/A N/A $50.9 -$89.97
Dec 2023 N/A N/A $19.38 -$117.28
Sep 2023 N/A N/A $15.8 -$211.55
Jun 2023 N/A N/A $16.6 -$183.6
Mar 2023 N/A N/A $14 -$162.52
Dec 2022 N/A N/A $10.18 -$139.88
Sep 2022 N/A N/A $12.8 -$21.32
Jun 2022 N/A N/A $20.6 -$22.2
Mar 2022 N/A N/A $37.6 -$22
Dec 2021 N/A N/A $96.4 -$22
Sep 2021 N/A N/A $144.6 -$21
Jun 2021 N/A N/A $184.6 -$16.2

NGNE average PE ratio chart

What is the average PE ratio of NGNE for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

NGNE PE vs peers

What is NGNE's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $230.28M
OMER Omeros Corp N/A $432M
ONVO Organovo Holdings Inc N/A $3.16M
ORIC Oric Pharmaceuticals Inc N/A $370.76M
ORMP Oramed Pharmaceuticals Inc N/A $89.46M
NGNE Neurogene Inc N/A $143.25M

Frequently asked questions

What is Neurogene's PE ratio?

The current price to earnings ratio of NGNE cannot be determined, as its EPS of -$4.28 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.